SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,958,527 | +5.6% | 197,645 | -0.2% | 0.05% | +10.9% |
| Q2 2023 | $22,689,275 | -12.1% | 198,125 | +5.8% | 0.05% | -17.9% |
| Q1 2023 | $25,821,761 | +35.2% | 187,345 | +27.1% | 0.06% | +30.2% |
| Q4 2022 | $19,094,909 | +32.3% | 147,360 | +12.8% | 0.04% | +19.4% |
| Q3 2022 | $14,438,000 | +838.1% | 130,610 | +536.2% | 0.04% | +800.0% |
| Q2 2022 | $1,539,000 | -2.2% | 20,530 | +2.0% | 0.00% | +33.3% |
| Q1 2022 | $1,573,000 | -13.2% | 20,130 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,813,000 | -53.3% | 20,130 | -11.6% | 0.00% | -66.7% |
| Q4 2020 | $3,881,000 | -6.3% | 22,766 | -22.9% | 0.01% | -10.0% |
| Q3 2020 | $4,144,000 | +290.9% | 29,514 | +346.3% | 0.01% | +233.3% |
| Q2 2020 | $1,060,000 | +554.3% | 6,613 | +299.3% | 0.00% | +200.0% |
| Q1 2020 | $162,000 | -55.2% | 1,656 | -40.9% | 0.00% | 0.0% |
| Q4 2019 | $362,000 | – | 2,803 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |